This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Subgroup analysis by sex and baseline BMI in people with a BMI ≥27 kg/m2 in the phase 2 trial of survodutide, a glucagon/GLP-1 receptor dual agonist.
Diabetes, obesity & metabolism, 27(4), 1773-1782
Citation
le Roux, Carel W; Steen, Oren; Lucas, Kathryn J; Startseva, Elena; Unseld, Anna; Hussain, Samina Ajaz; Hennige, Anita M. (2025). Subgroup analysis by sex and baseline BMI in people with a BMI ≥27 kg/m2 in the phase 2 trial of survodutide, a glucagon/GLP-1 receptor dual agonist.. Diabetes, obesity & metabolism, 27(4), 1773-1782. https://doi.org/10.1111/dom.16167